Objective-To determine the changes in ionised plasma calcium levels over a 24 h period in patients sustaining blunt trauma injuries and infused with the calcium containing colloid Haemaccel® (6.25 mmoll litre Ca2+). Methods-The study was carried out on 24 trauma patients who attended the accident and emergency (A&E) department of the Leicester Royal Infirmary and required fluid resuscitation. Nineteen patients, with a mean injury severity score (ISS) of 14 (range 6 to 36), were given an infusion of Haemaccel; five patients in the control group with an ISS of 12 (range 6 to 19) were infused non-calcium-containing crystalloid. All types of fluids were recorded and serial plasma ionised calcium values were measured over a 24 h period. A fall in plasma ionised calcium is a recognised metabolic response to traumatic and nontraumatic muscle damage,"q and intracellular calcium mobilisation following injury has been demonstrated in vitro in human endothelial monolayers.5 Nevertheless the role of calcium supplementation during fluid resuscitation in trauma patients remains controversial, as reflected by the fact that certain intravenous fluids used contain calcium whereas others do not. Haemaccel® is a calcium containing colloid which has a standard ionised calcium content of 6.25 mmol/litre and is commonly used, either alone or in combination with crystalloid,6 during resuscitation of shocked trauma patients in order to counteract the fall in plasma calcium in these patients.
A fall in plasma ionised calcium is a recognised metabolic response to traumatic and nontraumatic muscle damage,"q and intracellular calcium mobilisation following injury has been demonstrated in vitro in human endothelial monolayers.5 Nevertheless the role of calcium supplementation during fluid resuscitation in trauma patients remains controversial, as reflected by the fact that certain intravenous fluids used contain calcium whereas others do not. Haemaccel® is a calcium containing colloid which has a standard ionised calcium content of 6.25 mmol/litre and is commonly used, either alone or in combination with crystalloid,6 during resuscitation of shocked trauma patients in order to counteract the fall in plasma calcium in these patients.
It has, however, been observed that trauma patients who have received intravenous fluids containing calcium have significant prolongation of the bleeding time.7 This may be the result of inhibition of platelet aggregation by a direct effect of raised plasma calcium, as suggested previously.78
In the present study we have determined the level of plasma ionised calcium over a 24 hour period following resuscitation of trauma patients with Haemaccel.
Methods
Twenty four consecutive trauma patients admitted through Leicester Royal Infirmary accident and emergency (A&E) department and requiring fluid resuscitation were included in the study. Nineteen patients (mean age 36 years, age range 19 to 77) with a mean injury severity score (ISS) of 14 (range 6 to 36) were given an infusion of Haemaccel, and a control group of five patients (mean age 42 years, age range 18 to 85) with an ISS of 12 (range 6 to 19) were given non-calcium-containing crystalloids; all agreed to supply blood samples for the duration of the study. The ISS was assessed as previously described.9 None of the patients were on any medication, or had any underlying illness known to affect plasma calcium concentrations. All patients were resuscitated following the advanced trauma life support guidelines.'0 None of the patients had an arterial pH outside the normal range, as determined by blood gas analyser.
The fluid replacements were given in the usual way, with no modifications to patient management because of the study. The Hypercalcaemia (Ca" > 1.30 mmol/litre) was observed in at least one measurement in 50% of patients who were given Haemaccel infusions. In the trauma patients, following the infusion of Haemaccel the plasma ionised calcium concentration rose initially, but the levels then tended to fall, usually to below physiological levels, unless the infusion rate was maintained (fig 2) , indicating a persistence of the normal response to trauma. Since this normal response is to lower the plasma ionised calcium, then raising the concentrations, especially above physiological values, may be deleterious for primary haemostatic mechanisms and cell function. In our study the calcium was raised, and quite markedly so, since the supranormal levels seen were superimposed on a low physiological level.
The high ionised calcium level may also reduce platelet aggregation by enhancing the rate of platelet disaggregation. There is an optimum concentration of extracellular plasma calcium required for platelet aggregation to be achieved.8 When the level of calcium goes above this optimum level the extent of platelet aggregation is reduced by enhancing the rate of disaggregation, and this could be one of the factors that leads to an increase in bleeding time seen in the trauma patient.
The inhibitory effect of calcium on platelet aggregation in vitro8 and the prolongation of the bleeding time in traumatised patients following infusion of Haemaccel7 has, however, to be contrasted with the potentially detrimental effects of low plasma ionised calcium concentrations on myocardial function and the circulation.'3 However, the shocked trauma patient has a greater tendency to hypoxic cellular damage due to hypoperfusion and hypostatic flow in vascular capillary beds, and infusing calcium containing fluids into these patients may increase the likelihood of influx of calcium into the cells.'4 Previous investigators have suggested that this intracellular accumulation of calcium may be one of the reasons for a change from reversible to irreversible cell injury and death."5 The potential detrimental effects may therefore outweigh the benefits of the positive inotropic effects on the heart and the increase in vascular tone which may follow calcium infusion.
Further research is required to establish the optimal plasma calcium concentrations to be achieved following trauma.
